Warnings & Recalls for Myrbetriq
Myrbetriq and Pregnancy
Myrbetriq is an FDA pregnancy Category C
medication. It is not known
if Myrbetriq may cause harm to the fetus
when taken by a pregnant woman. It is also unknown
if a Myrbetriq may transfer through breast-milk and harm a nursing baby. Do not take Myrbetriq without consulting your doctor if you are pregnant
, are planning on becoming pregnant,
or are breastfeeding
Patients who may be allergic
to the ingredients of Myrbetriq should not
use this medicine as a treatment for an overactive bladder.
Let your doctor know about any medical conditions
you may have and ask your doctor if it is safe to use Myrbetriq if you:
- have any allergies
- have high blood pressure
- have a history of urinary tract infection
- have any bladder obstructions
- are pregnant or breastfeeding
- are taking or have been taking any other medicines
Myrbetriq should be used with caution in patients with hypertension
as it may cause an increase in blood pressure. Myrbetriq may also increase the risk of developing a urinary tract infection
Myrbetriq Treatment and Use
Myrbetriq | mirabegron is classified as a beta-3 adrenergic agonist medicine marketed by Astellas Pharma US Inc. for treating side effects of an overactive bladder. Myrbetriq was approved by the U.S. Food and Drug Administration on June 23, 2012 for treating uncontrollable bladder problems in adults.
Myrbetriq may benefit patients through the following:
- reducing the urgency to urinate
- preventing urge urinary incontinence (uncontrolled loss of urine)
- decreasing the need to urinate more often than normal
How Does Myrbetriq Work?
Patients with an overactive bladder suffer from symptoms of frequent urination, trouble urinating, and urgency to urinate. Mybetriq prevents and reduces these symptoms by relaxing muscles in the bladder and increasing the size to allow for more storage.
How to Use Myrbetriq
Myrbetriq is an extended-release tablet which is to be taken by mouth. Myrbetriq should be taken once daily in 25 mg doses. Some patients may be instructed to take Myrbetriq in 50 mg doses after using Myrbetriq for an extended period of time. Swallow Myrbetriq whole with a full glass of water, with or without food. Do not break or chew tablets. Take Myrbetriq as prescribed by your doctor.
It may take up to two months to see signs of improvement.
Patients should have their blood checked regularly while taking Myrbetriq.